NMOSD restriction and item codes
Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
PBS NMOSD restriction and item codes
Ravulizumab NMOSD loading dose and vial calculator (patients ≥ 40kg)
Table 1
Body weight | Loading dose | Number of 300mg vials | Number of 1100mg vials |
40kg to less than 60kg | 2400mg | 8 | 0 |
60kg to less than 100kg | 2700mg | 9 | 0 |
100kg and over | 3000mg | 10 | 0 |
Ravulizumab NMOSD maintenance dose and vial calculator (patients ≥ 40kg)
Table 2
Body weight | Maintenance dose | Number of 300mg vials | Number of 1100mg vials |
40kg to less than 60kg | 3000mg | 10 | 0 |
60kg to less than 100kg | 3300mg | 0 | 3 |
100kg and over | 3600mg | 1 | 3 |
Contact details
PBS Complex Drugs Programs
Forms
Neuromyelitis optica spectrum disorder - ravulizumab - initial authority application form (PB382)
Services Australia website
Neuromyelitis optica spectrum disorder
External website
PBS schedule for neuromyelitis optics spectrum disorder
FAQs from Service Officers
Table 3: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs
Item | Description |
1 | Is there an age restriction for PBS-subsidised ravulizumab to treat NMOSD? No. Patients of any age can apply for ravulizumab. However, as dosing must align with the TGA-approved product information, patients must be at least 40kg. |
2 | Can replacement or top-up prescriptions be approved using Balance of Supply (BoS) item codes? No. There are no BoS item codes. Replacement and top-up prescriptions will need to be entered under previously approved item code and restriction. |
3 | Where are the dosing schedules for NMOSD located? Dosing tables can be found on the: - Master code sheet
- NMOSD individual code sheet, and
- Tables 1 and 2 on this page
|
4 | Can a prescriber request a loading dose and continuing treatment with the initial application? No. The initial application should only include script(s) for the loading dose. Continuing treatment can then be requested via telephone or using the Online PBS Authorities system before the dose is due (two weeks after loading dose is given). |
5 | What other PBS-subsidised conditions is ravulizumab listed to treat? - Atypical haemolytic uraemic syndrome (aHUS). Refer all aHUS requests to a pharmaceutical adviser
- Paroxysmal nocturnal haemoglobinuria (PNH), and
- Generalised myasthenia gravis (gMG)
|
Expand all